Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00093275 · ClinicalTrials.gov registry record · Phase 2
HP184 in Chronic Spinal Cord Injury Subjects
A Phase 2 study, sponsored by Sanofi.
- Completed
- Registry status
- Phase 2
- Development phase
- 262
- Enrollment target
NCT00093275: Completed Phase 2 study, sponsored by Sanofi.
NCT00093275 is a Phase 2 study that has completed, run by Sanofi. The registered enrollment target is 262 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00093275, a Phase 2 study, has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 262 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether HP184 is effective in the treatment of chronic spinal cord injury (CSCI).
Interventions
- DRUG HP184
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2004-10 |
| Est. Completion | 2005-12 |
| Phase | Phase 2 |
What the finished NCT00093275 record still lists
NCT00093275 is an interventional study that assigns participants to a tested intervention. The registered 262 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% higher).
The record links to 0 conditions, and to 1 intervention - of which HP184 is the first listed.
NCT00093275 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00093275 about?
NCT00093275 is a clinical study titled "HP184 in Chronic Spinal Cord Injury Subjects". The purpose of this study is to determine whether HP184 is effective in the treatment of chronic spinal cord injury (CSCI).
What is the current status of trial NCT00093275?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 262 participants. The study started on 2004-10. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00093275?
The interventions under investigation include: HP184 (DRUG).
Who is sponsoring clinical trial NCT00093275?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00093275's enrollment target sits among peer trials
262 210th of 2000 higher than 1,791 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03713268 · 262 participants
Intraoperative OCT Guidance of Intraocular Surgery II
- NCT06074380 · 262 participants · Phase 4
Non Inferiority Trial Investigating Surfactants Administered Via MIST
- NCT06293703 · 262 participants · NA
Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)
- NCT06780137 · 262 participants · Phase 1
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia